Roivant Sciences Ltd.（ROIV）· 损益表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。

FMP · ROIV · 截至 2026-06-08

财务报表

Revenue · Gross Profit · Net Income

Breakdown	2026-03	2025-03	2024-03	2023-03	2022-03
Revenue
Revenue	$8.26M	$29.05M	$32.71M	$31.53M	$55.29M
Cost of Revenue	$1.28M	$0.91M	$1.60M	$3.03M	$8.97M
Gross Profit	$6.97M	$28.14M	$31.11M	$28.50M	$46.32M
Gross Margin %(computed)	84.44%	96.86%	95.11%	90.38%	83.78%
Operating Expenses
R&D Expenses	$681.81M	$550.41M	$439.91M	$454.06M	$483.04M
G&A Expenses	$610.47M	$591.41M	$416.13M	$383.45M	$775.03M
Total Operating Expenses	$1292.28M	$1141.82M	$856.04M	$837.51M	$1258.07M
Operating Income	($1285.30M)	($1113.68M)	($824.93M)	($809.01M)	($1211.75M)
Operating Margin %(computed)	—	—	—	—	—
Interest Income	$178.11M	$258.38M	$146.43M	$32.18M	$0.37M
Interest Expense	$0.00M	$0.00M	$34.78M	$27.97M	$7.04M
Income Before Tax	($264.58M)	($681.59M)	$4567.86M	($884.99M)	($923.75M)
Income Tax Expense	$133.33M	$48.17M	$21.50M	$4.08M	$0.37M
Net Income	($299.77M)	($171.98M)	$4348.93M	($1009.03M)	($845.26M)
Net Margin %(computed)	—	-591.96%	—	—	—
Per Share & EBITDA
EPS (Basic)	$-0.43	$-0.24	$5.55	$-1.42	$-1.26
Wtd Avg Shares	693.86M	725.40M	783.25M	712.79M	669.75M
EBITDA	($1281.95M)	($1099.61M)	($802.89M)	($790.16M)	($910.77M)
EBITDA Margin %(computed)	—	—	—	—	—